Francois P. Vandervegt

Array ( [id] => 421993 [patent_doc_number] => 07273925 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-09-25 [patent_title] => 'Methods and products for regulating lectin complement pathway associated complement activation' [patent_app_type] => utility [patent_app_number] => 09/464303 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 19600 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273925.pdf [firstpage_image] =>[orig_patent_app_number] => 09464303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408206 [patent_doc_number] => 07285524 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-23 [patent_title] => 'Allo and auto-reactive T-cell epitopes' [patent_app_type] => utility [patent_app_number] => 09/857097 [patent_app_country] => US [patent_app_date] => 1999-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6024 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285524.pdf [firstpage_image] =>[orig_patent_app_number] => 09857097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 936928 [patent_doc_number] => RE038916 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2005-12-06 [patent_title] => 'APC Antibodies' [patent_app_type] => reissue [patent_app_number] => 09/442489 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 42 [patent_no_of_words] => 18024 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038916.pdf [firstpage_image] =>[orig_patent_app_number] => 09442489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 702208 [patent_doc_number] => 07064190 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-20 [patent_title] => 'Antigen-specific, activated T lymphocytes, detection and use' [patent_app_type] => utility [patent_app_number] => 09/441061 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9738 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/064/07064190.pdf [firstpage_image] =>[orig_patent_app_number] => 09441061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020846 [patent_doc_number] => 06887474 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Compositions and methods for producing vascular occlusion' [patent_app_type] => utility [patent_app_number] => 09/438944 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9357 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887474.pdf [firstpage_image] =>[orig_patent_app_number] => 09438944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476216 [patent_doc_number] => 20020151690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'PURIFICATION OF ANTIGEN-SPECIFIC T CELLS' [patent_app_type] => new [patent_app_number] => 09/434965 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 9399 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151690.pdf [firstpage_image] =>[orig_patent_app_number] => 09434965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231938 [patent_doc_number] => 06693169 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Laminin 5, 13 and 14 and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/415625 [patent_app_country] => US [patent_app_date] => 1999-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19413 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693169.pdf [firstpage_image] =>[orig_patent_app_number] => 09415625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4247922 [patent_doc_number] => 06207386 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Compositions for the treatment and diagnosis of body weight disorders, including obesity' [patent_app_type] => 1 [patent_app_number] => 9/406071 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 30876 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207386.pdf [firstpage_image] =>[orig_patent_app_number] => 406071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380495 [patent_doc_number] => 06294381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'CD123+ dendritic cells in blood and lymphoid tissues' [patent_app_type] => 1 [patent_app_number] => 9/391946 [patent_app_country] => US [patent_app_date] => 1999-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 2040 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294381.pdf [firstpage_image] =>[orig_patent_app_number] => 391946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247525 [patent_doc_number] => 06673346 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Compositions and methods for the treatment of sepsis' [patent_app_type] => B1 [patent_app_number] => 09/387671 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17958 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673346.pdf [firstpage_image] =>[orig_patent_app_number] => 09387671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292506 [patent_doc_number] => 06183991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Testis-specific insulin homolog polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/314051 [patent_app_country] => US [patent_app_date] => 1999-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19916 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183991.pdf [firstpage_image] =>[orig_patent_app_number] => 314051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020849 [patent_doc_number] => 06887475 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Notch' [patent_app_type] => utility [patent_app_number] => 09/310685 [patent_app_country] => US [patent_app_date] => 1999-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 8228 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887475.pdf [firstpage_image] =>[orig_patent_app_number] => 09310685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4270074 [patent_doc_number] => 06280731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Antithrombotic agent and anti-von willebrand factor monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 9/299016 [patent_app_country] => US [patent_app_date] => 1999-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 11385 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280731.pdf [firstpage_image] =>[orig_patent_app_number] => 299016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186639 [patent_doc_number] => 06153373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Method for sex determination of mammalian offspring' [patent_app_type] => 1 [patent_app_number] => 9/299181 [patent_app_country] => US [patent_app_date] => 1999-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1959 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153373.pdf [firstpage_image] =>[orig_patent_app_number] => 299181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4317609 [patent_doc_number] => 06248560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Analogs of macrophage stimulating protein' [patent_app_type] => 1 [patent_app_number] => 9/296219 [patent_app_country] => US [patent_app_date] => 1999-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10909 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248560.pdf [firstpage_image] =>[orig_patent_app_number] => 296219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435836 [patent_doc_number] => 06355479 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'MHC class II antigen-presenting systems and methods for activating CD4 T cells' [patent_app_type] => B1 [patent_app_number] => 09/194285 [patent_app_country] => US [patent_app_date] => 1999-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 27488 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355479.pdf [firstpage_image] =>[orig_patent_app_number] => 09194285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418745 [patent_doc_number] => 06225044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Method for gene transfer into cells activated from a quiescent state' [patent_app_type] => 1 [patent_app_number] => 9/287623 [patent_app_country] => US [patent_app_date] => 1999-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11262 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225044.pdf [firstpage_image] =>[orig_patent_app_number] => 287623 [rel_patent_id] =>[rel_patent_doc_number] =>)